Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

par Bain, Stephen C., Mosenzon, Ofri, Arechavaleta, Rosario, Bogdański, Pawel, Comlekci, Abdurrahman, Consoli, Agostino, Deerochanawong, Chaicharn, Dungan, Kathleen, Faingold, Maria C., Farkouh, Michael E., Franco, Denise R., Gram, Jeppe, Guja, Cristian, Joshi, Pankaj, Malek, Rachid, Merino‐Torres, Juan F., Nauck, Michael A., Pedersen, Sue D., Sheu, Wayne H. ‐H., Silver, Robert J., Tack, Cees J., Tandon, Nikhil, Jeppesen, Ole K., Strange, Mette, Thomsen, Mette, Husain, Mansoor
Publié dans Diabetes Obes Metab (2018)

Efficiency of chemical versus mechanical disruption methods of DNA extraction for the identification of oral Gram-positive and Gram-negative bacteria

par Li, Xiaolan, Bosch-Tijhof, Caroline J., Wei, Xi, de Soet, Johannes J., Crielaard, Wim, van Loveren, Cor, Deng, Dong Mei
Publié dans J Int Med Res (2020)

Effectiveness of oral antibiotics for definitive therapy of non-Staphylococcal Gram-positive bacterial bloodstream infections

par Quinn, Nicholas J., Sebaaly, Jamielynn C., Patel, Bianka A., Weinrib, David A., Anderson, William E., Roshdy, Danya G.
Publié dans Ther Adv Infect Dis (2019)

A role for glycosylated Serine-rich repeatproteins in Gram-positive bacterial pathogenesis

par Lizcano, Anel, Sanchez, Carlos J., Orihuela, Carlos J.
Publié 2012

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy

par Sinclair, Emily, Frens, Jeremy J, Zeigler, Dustin, Mccarthy, Megan, Sharma, Roopali
Publié dans Open Forum Infect Dis (2020)

Phospholipid composition of gliding bacteria: oral isolates of Capnocytophaga compared with Sporocytophaga.

par Holt, S C, Doundowlakis, J, Takacs, B J
Publié 1979

200. Real-World Experience with Dalbavancin for Complicated Gram-Positive Infections: A Multicenter Evaluation

par Alosaimy, Sara, Pearson, Jeffrey, Veve, Michael, Dionne, Brandon, Aleissa, Muneerah, Jorgensen, Sarah C J, Rybak, Michael J
Publié dans Open Forum Infect Dis (2019)

Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia

par Erickson, Reaghan M, Tritle, Brandon J, Spivak, Emily S, Timbrook, Tristan T
Publié dans Open Forum Infect Dis (2019)

An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study

par Li, K, Hüsing, A, Fortner, R T, Tjønneland, A, Hansen, L, Dossus, L, Chang-Claude, J, Bergmann, M, Steffen, A, Bamia, C, Trichopoulos, D, Trichopoulou, A, Palli, D, Mattiello, A, Agnoli, C, Tumino, R, Onland-Moret, N C, Peeters, P H, Bueno-de-Mesquita, H B(as), Gram, I T, Weiderpass, E, Sánchez-Cantalejo, E, Chirlaque, M-D, Duell, E J, Ardanaz, E, Idahl, A, Lundin, E, Khaw, K-T, Travis, R C, Merritt, M A, Gunter, M J, Riboli, E, Ferrari, P, Terry, K, Cramer, D, Kaaks, R
Publié dans Br J Cancer (2015)

Sink flora in a long-stay hospital is determined by the patients' oral and rectal flora.

par Van Saene, H. K., Van Putte, J. C., Van Saene, J. J., Van de Gronde, T. W., Van Warmerdam, E. G.
Publié 1989

Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable...

par Werth, Brian J.
Publié dans J Antimicrob Chemother (2017)

1290. Real-World Experience with Omadacycline for Nontuberculous Mycobacterial and Gram-Negative Infections: A Multicenter Evaluation

par Morrisette, Taylor, Philley, Julie V, Sigler, Carly, Frens, Jeremy J, Webb, Andrew J, Stevens, Ryan W, Howard, Catessa, Bouchard, Jeannette, Bookstaver, P B, Barger, Melissa, Lagnf, Abdalhamid M, Alosaimy, Sara, Rybak, Michael J
Publié dans Open Forum Infect Dis (2020)

131. Duration of Therapy for the Treatment of Gram-Negative Bloodstream Infections

par Shulder, Stephanie, O’Connell, Matthew, Agedal, Kaitlyn J, Conn, Kelly M, Pillinger, Kelly E
Publié dans Open Forum Infect Dis (2019)

Management of non-gonococcal urethritis

par Moi, Harald, Blee, Karla, Horner, Patrick J
Publié dans BMC Infect Dis (2015)

Non‐oral, aerobic, Gram‐negative bacilli in the oral cavity of Thai HIV‐positive patients on Highly‐active anti‐retrovirus therapy medication

par Arirachakaran, Pratanporn, Luangworakhun, Sureeat, Charalampakis, Georgios, Dahlén, Gunnar
Publié dans J Investig Clin Dent (2019)

Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants

par Foong, Siew Cheng, Tan, May Loong, Foong, Wai Cheng, Marasco, Lisa A, Ho, Jacqueline J, Ong, Joo Howe
Publié dans Cochrane Database Syst Rev (2020)

Fatty acid composition of gliding bacteria: oral isolates of Capnocytophaga compared with Sporocytophaga.

par Holt, S C, Forcier, G, Takacs, B J
Publié 1979

Anti-CA15.3 and anti-CA125 antibodies and ovarian cancer risk: Results from the EPIC cohort

par Cramer, Daniel W., Fichorova, Raina N., Terry, Kathryn L., Yamamoto, Hidemi, Vitonis, Allison F., Ardanaz, Eva, Aune, Dagfinn, Boeing, Heiner, Brändstedt, Jenny, Boutron-Ruault, Marie-Christine, Chirlaque, Maria-Dolores, Dorronsoro, Miren, Dossus, Laure, Duell, Eric J, Gram, Inger T., Gunter, Marc, Hansen, Louise, Idahl, Annika, Johnson, Theron, Khaw, Kay-Tee, Krogh, Vittorio, Kvaskoff, Marina, Mattiello, Amalia, Matullo, Giuseppe, Merritt, Melissa A., Nodin, Björn, Orfanos, Philippos, Onland-Moret, N. Charlotte, Palli, Domenico, Peppa, Eleni, Quirós, J. Ramón, Sánchez, Maria-Jose, Severi, Gianluca, Tjønneland, Anne, Travis, Ruth C., Trichopoulou, Antonia, Tumino, Rosario, Weiderpass, Elisabete, Fortner, Renée T., Kaaks, Rudolf
Publié dans Cancer Epidemiol Biomarkers Prev (2018)

The core genome of the anaerobic oral pathogenic bacterium Porphyromonas gingivalis

par Brunner, Jorg, Wittink, Floyd RA, Jonker, Martijs J, de Jong, Mark, Breit, Timo M, Laine, Marja L, de Soet, Johannes J, Crielaard, Wim
Publié 2010

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis

par Zhanel, George G., Walkty, Andrew J., Karlowsky, James A.
Publié dans Can J Infect Dis Med Microbiol (2016)